Neuroendocrine & Receptor Models

This selection houses structural peptide analogs utilized to research complex neuroendocrine pathways and glandular receptor interactions. These compounds are isolated to study the somatotropic axis (growth hormone secretagogues), melanocortin receptor binding (MC1R - MC5R), and neuromodulatory factors in highly controlled in-vitro and animal models.

Not for human consumption or cosmetic application.

CJC-1295 without DAC

A synthetic, 29-amino acid analogue of growth hormone-releasing hormone (also known as Mod GRF 1-29). Utilized to investigate short-acting GHRH receptor binding and pulsatile somatotrope signaling.

Tesamorelin

A synthetic, N-terminally modified analogue of growth hormone-releasing hormone (GHRH). Utilized to investigate targeted visceral adipose reduction pathways and basal growth hormone pulsatility.

CJC-1295 + Ipamorelin

A synergistic co-formulation of a GHRH analogue and a selective GHSR-1a agonist. Utilized to investigate amplified, pulsatile growth hormone secretion via dual-receptor activation.

Melanotan 2

A synthetic, cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). Utilized to investigate non-selective melanocortin receptor agonism, melanogenesis, and neuro-arousal pathways.

PT-141

A synthetic peptide (Bremelanotide) acting as a potent, non-selective agonist of the melanocortin receptors. Utilized to investigate central nervous system mechanisms of arousal via MC4R signaling.

Semax

A synthetic heptapeptide analogue derived from adrenocorticotropic hormone (ACTH 4-10). Utilized to investigate BDNF/NGF expression, neuroprotection, and cognitive pathway modulation.